Healthcare News & Insights

Key drug to prevent preemies to increase from $20/shot to $1,500

The FDA approved a commercial version of a progesterone shot used by women at risk for pre-term birth — but the approval actually makes the drug much harder to get for most patients.

Patient paranoia: Odds are new site makes it worse

Get ready for more paranoid patients and rousing trivia contests in the break rooms. A new “all-factoid” site provides plenty of ammunition for both.